NCT05919030 2024-11-14A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell CarcinomaRenmin Hospital of Wuhan UniversityPhase 3 Recruiting155 enrolled